Jason had spent years helping others decode their emotional undercurrents. A digital and brand-strategy specialist by trade, he called himself a natural mentor. “Put me in a situation where people are challenged, and I light up,” he would say.
He liked making people feel at ease. But the man who lit up rooms carried an “invisible weight.” He had major depressive disorder—MDD—a condition defined by five or more symptoms: depressed mood, loss of interest, trouble concentrating, guilt, low energy.
Jason experienced many of them. Depressed mood. Loss of interest in things he once loved.
Fatigue. Sleeplessness.
Poor concentration. Restlessness. Outwardly, he performed.
High marks at work. A happy marriage to a supportive husband. Inside, the weight stayed.
His psychiatrist prescribed antidepressants. Jason took them.
Then came the side effects. One of the hardest was sexual dysfunction. It started after he began various treatments his doctor prescribed.
For communities across Asia, this reality is rarely discussed openly. Yet it affects many families living with depression.
Jason had to have honest conversations with his psychiatrist about it. He had to understand that the side effect was part of the treatment process, not a personal failing.
The unspoken cost of treatment
Sexual dysfunction as a side effect of antidepressants is well-documented in medical literature. But for patients like Jason, the clinical term “treatment-emergent sexual dysfunction” translates into something far more personal. It can strain relationships.
It can make a person feel broken in a new way, on top of the depression itself. Jason’s story points to a gap in how depression care is delivered.
The condition itself—MDD—is already isolating. Add a side effect that carries its own stigma, and many patients simply stop taking their medication. They do not tell their doctor why.
Jason did tell. He worked through it.
That required trust. It required a psychiatrist willing to have the conversation. And it required Jason to see the side effect as part of the journey, not a verdict on his worth.
For ordinary people, the lesson is blunt: managing depression is rarely a straight line. The medication that lifts the fog can bring new problems. The problems need to be named.
They need to be discussed. Jason’s background gave him some tools.
As someone who decoded emotional undercurrents for a living, he understood the value of naming what was wrong. But even he struggled. The invisible weight did not lift all at once.
It shifted. It changed shape.
He kept talking. Across Asia, cultural taboos around mental health and sex compound the issue. Many patients suffer in silence.
They assume the dysfunction is permanent. They assume it is their fault. Jason’s experience suggests otherwise.
The open dialogue with his healthcare professional made the difference. It is not a cure.
It is a process. And for the millions living with MDD across the region, that process starts with one honest sentence spoken in a doctor’s office. Jason is still managing his depression.
He is still taking treatment. He is still the mentor who lights up when others struggle.
But now he knows: the invisible weight sometimes needs to be talked about out loud.
